Intended Audience

Nurses, physicians, radiologists, pathologists, residents, medical students, and other interested health care professionals who are interested in oncology.

Learning Objectives

1. Understand which patients should receive neoadjuvant systemic treatment.
2. Understand if neoadjuvant treatment improves survival.
3. Understand which regimens are best.

Moderators

Susan Beck, DO, FACOS
Katzmann Breast Center at Mercy
Biography

Brian P. Freeman, MD
Medical Oncology and Hematology Associates of Iowa
​Biography

Richard L. Deming
Mercy Cancer Center & CyberKnife Radiosurgery Center of Iowa
​Biography

Drs. Beck, Freeman, and Deming all indicated they have no financial relationships to disclose relevant to the content of this CME activity.

Disclosure

Speaker(s) will disclose to attendees the nature of any financial relationships they have with the commercial firms providing support as well as the commercial manufacturers of products and/or the providers of services discussed in their presentations. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA).

Continuing Education Credit

DO: This activity has been planned and implemented in accordance with the guidelines from the American Osteopathic Association (AOA) through the sponsorship of Des Moines University (DMU) and Mercy Medical Center - Des Moines. DMU is accredited by the AOA and approves this live activity for 1.0 hour of AOA Category 1-B CME credit.